Your session is about to expire
← Back to Search
Millipede System for Ischemic Stroke (MARRS Trial)
MARRS Trial Summary
This trial looks at safety & effectiveness of a device to treat stroke due to blocked arteries & associated patient outcomes.
MARRS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMARRS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MARRS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the enrollment criteria of this experiment conducive to geriatric patients?
"This medical trial is searching for participants aged over 18 and below 85 years old."
Are new participants being accepted for enrollment in this trial?
"Affirmative. According to the clinicaltrials.gov, this medical research was put up for public view on October 9th 2023 and has been recently revised on November 15th of the same year. It is presently searching for 225 volunteers that will be examined at 13 different clinical trial sites."
Is there an opportunity to participate in this medical investigation?
"In order to qualify, potential candidates must have experienced a stroke and should be between 18-85 years old. Currently, the trial is attempting to acquire 225 participants."
Are there any Canadian centers hosting this medical investigation?
"To date, 13 different medical centres are enrolled in the trial. These include Oregon Health & Science University (OHSU) in Portland, Hôpital Fondation Adolphe de Rothschild in Paris and Vall d'Hebron Hospital in Barcelona among other locations."
How many participants are engaged in this medical experimentation?
"To successfully execute this trial, 225 eligible patients will be needed. Perfuze is overseeing the recruiting process from two sites: OHSU in Portland, Oregon and Hôpital Fondation Adolphe de Rothschild in Paris, Connecticut."
Share this study with friends
Copy Link
Messenger